Yabao Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate
Yabao Pharmaceutical Group Co Ltd cash flow reinvestment rate. Yabao Pharmaceutical Group Co Ltd (600351) has a Cash Flow Reinvestment Rate of 0.06x as of September 2025, reinvesting CN¥7.58 Million (capex CN¥7.58 Million ) from operating cash flow of CN¥129.49 Million. Explore Yabao Pharmaceutical Group Co Ltd (600351) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Yabao Pharmaceutical Group Co Ltd (2001–2024)
Cash flow reinvestment rate of Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. Historical reinvestment intensity for Yabao Pharmaceutical Group Co Ltd across 22 annual periods. Explore 600351 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Yabao Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate by Year (2001–2024)
Yabao Pharmaceutical Group Co Ltd cash flow reinvestment rate by year from 2001 to 2024. Year-by-year capital reinvestment analysis for Yabao Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Yabao Pharmaceutical Group Co Ltd cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.07x | CN¥34.77 Million | CN¥471.69 Million | CN¥34.66 Million | ▼ -83.9% |
| 2023 | 0.46x | CN¥227.23 Million | CN¥497.55 Million | CN¥99.86 Million | ▲ +32.3% |
| 2022 | 0.35x | CN¥158.96 Million | CN¥460.46 Million | CN¥62.23 Million | ▲ +14.4% |
| 2021 | 0.30x | CN¥132.04 Million | CN¥437.50 Million | CN¥95.05 Million | ▼ -45.6% |
| 2020 | 0.55x | CN¥211.38 Million | CN¥380.96 Million | CN¥62.87 Million | ▲ +25.6% |
| 2019 | 0.44x | CN¥187.75 Million | CN¥425.17 Million | CN¥157.09 Million | ▲ +124.1% |
| 2018 | 0.20x | CN¥84.06 Million | CN¥426.60 Million | CN¥68.01 Million | ▼ -74.1% |
| 2017 | 0.76x | CN¥122.98 Million | CN¥161.73 Million | CN¥99.34 Million | ▲ +21.5% |
| 2016 | 0.63x | CN¥97.61 Million | CN¥155.95 Million | CN¥84.46 Million | ▼ -24.0% |
| 2015 | 0.82x | CN¥118.14 Million | CN¥143.47 Million | CN¥101.68 Million | ▼ -15.4% |
| 2014 | 0.97x | CN¥173.84 Million | CN¥178.63 Million | CN¥173.84 Million | ▼ -44.2% |
| 2013 | 1.74x | CN¥99.02 Million | CN¥56.80 Million | CN¥99.02 Million | ▼ -40.6% |
| 2011 | 2.94x | CN¥119.56 Million | CN¥40.73 Million | CN¥119.56 Million | ▼ -70.9% |
| 2010 | 10.09x | CN¥187.30 Million | CN¥18.57 Million | CN¥187.30 Million | ▲ +1278.1% |
| 2009 | 0.73x | CN¥269.82 Million | CN¥368.56 Million | CN¥269.82 Million | ▼ -48.9% |
| 2008 | 1.43x | CN¥147.56 Million | CN¥102.90 Million | CN¥147.56 Million | ▲ +384.1% |
| 2007 | 0.30x | CN¥31.31 Million | CN¥105.69 Million | CN¥31.31 Million | ▼ -92.1% |
| 2006 | 3.77x | CN¥43.70 Million | CN¥11.59 Million | CN¥43.70 Million | ▼ -8.7% |
| 2005 | 4.13x | CN¥108.95 Million | CN¥26.40 Million | CN¥108.95 Million | ▲ +62.3% |
| 2004 | 2.54x | CN¥202.81 Million | CN¥79.73 Million | CN¥202.81 Million | ▲ +125.7% |
| 2002 | 1.13x | CN¥27.38 Million | CN¥24.29 Million | CN¥27.38 Million | ▲ +15.4% |
| 2001 | 0.98x | CN¥23.04 Million | CN¥23.59 Million | CN¥23.04 Million | — |